News
AOD-9604 as a Muscle-Sparing Alternative: What ...
The ACP's new obesity guidelines endorse GLP-1 agonists but leave muscle-loss risk unaddressed. AOD-9604 research suggests a fat-selective mechanism—yet evidence remains preliminary.
AOD-9604 as a Muscle-Sparing Alternative: What ...
The ACP's new obesity guidelines endorse GLP-1 agonists but leave muscle-loss risk unaddressed. AOD-9604 research suggests a fat-selective mechanism—yet evidence remains preliminary.